...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >CoMFA and docking studies on triazolopyridine oxazole derivatives as p38 MAP kinase inhibitors.
【24h】

CoMFA and docking studies on triazolopyridine oxazole derivatives as p38 MAP kinase inhibitors.

机译:CoMFA和三唑并吡啶恶唑衍生物作为p38 MAP激酶抑制剂的对接研究。

获取原文
获取原文并翻译 | 示例
           

摘要

With the objective to design new chemical entities with enhanced inhibitory potencies against p38 MAP alpha kinase, the 3D-QSAR and Comparative Molecular Field Analysis (CoMFA) studies were carried out on triazolopyridine oxazole compounds as inhibitors of these kinase is presented here. The developed model gave q(2) value of 0.707 and r(2) value of 0.942 for CoMFA. The high leave-one-out (LOO) cross-validated correlation coefficient q(2) reveals that the model is a useful tool for the prediction of test set of 19 compounds that were not included in the training set of 55 compounds. The results not only lead to better understanding of structural requirements of p38 alpha inhibitors but also can help in the design of new potent inhibitors. The binding mode of the compounds at the active site of p38 MAP alpha kinase was explored using Glide docking program and hydrogen-bonding interactions were observed between the inhibitors and the target. The details of amino acid interactions of the active site are discussed briefly and correlated with the contour plots.
机译:为了设计具有增强的针对p38 MAPα激酶的抑制力的新化学实体,对三唑并吡啶恶唑化合物进行了3D-QSAR和比较分子场分析(CoMFA)研究,因为此处介绍了这些激酶的抑制剂。对于CoMFA,开发的模型给出的q(2)值为0.707,r(2)值为0.942。高留一法(LOO)交叉验证的相关系数q(2)表明,该模型是预测19种化合物的测试集的有用工具,而55种化合物的训练集未包括该测试集。结果不仅可以使人们更好地理解p38α抑制剂的结构要求,而且可以帮助设计新的有效抑制剂。使用Glide对接程序探索了化合物在p38 MAPα激酶活性位点的结合模式,并在抑制剂和靶标之间观察到氢键相互作用。简要讨论了活性位点氨基酸相互作用的细节,并将其与等高线图相关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号